Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment
- PMID: 31246285
- DOI: 10.1111/trf.15419
Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment
Abstract
Donor red cell genotyping provides efficiencies to identify "in demand" blood donors for transfusion recipients requiring antigen-negative blood. Donor red cell genotype information can be used to label units with historical types and introduced throughout the supply chain from the blood center to the hospital transfusion service and has potential to be used in recruitment strategies.
© 2019 AABB.
References
REFERENCES
-
- Perreault J, Lavoie J, Painchaud P, et al. Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang 2009;97:61-8.
-
- Denomme GA. Prospects for the provision of genotyped blood for transfusion. Br J Haematol 2013;163:3-9.
-
- Hopp K, Weber K, Bellissimo D, et al. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010;50:40-6.
-
- Flegel WA, Gottschall JL, Denomme GA. Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol 2015;2:e282-9.
-
- Center for Biologics Evaluation and Research. Labeling of red blood cell units with historical antigen typing results: guidance for industry [monograph on the internet]. Silver Spring (MD): Food and Drug Administration; 2018 [cited 2019 May 06]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceR....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
